Zephyrnet Logo

Generative Data Intelligence

Tag: effector

NMPA Usability Engineering Guideline Issued for Medical Devices

Medical Devices
NMPA published the “Medical Devices Usability Engineering Guideline” on March 19, 2024. NMPA believes that, in improving the usability and the design of devices...

Top News

Patent Office Issued 230 Patents to Indiana Entities in December 2023

Patents
The U.S. Patent Office issued the following 230 patents to persons and businesses in Indiana in December 2023: PATENT NUMBER                                    PATENT TITLE US 11851685 B2 Zwitterion buffer containing...

SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology | BioSpace

Medical Devices
DENVER, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases – Nature Nanotechnology

Nano Technology
Klotter, V. et al. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study. PLoS...

Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy – Nature Nanotechnology

Nano Technology
Ramsey, A. V., Bischoff, A. J. & Francis, M. B. Enzyme activated gold nanoparticles for versatile site-selective bioconjugation. J. Am. Chem. Soc. 143, 7342–7350...

SeaStar Medical Appoints David A. Green as Chief Financial Officer | BioSpace

Medical Devices
DENVER, Jan. 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications | BioSpace

Medical Devices
DENVER, Jan. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

SeaStar Medical builds enrolment in pivotal trial for AKI device

Medical Devices

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury | BioSpace

Medical Devices
DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity – Nature Nanotechnology

Nano Technology
Saxena, M., van der, Burg, S. H., Melief, C. J. M. & Bhardwaj, N. Therapeutic cancer vaccines. Nat. Rev. Cancer 21, 360–378 (2021).Article  ...

CAR T Cell Immunotherapy And The Quiet Hope For A Universal Cancer Treatment

IOT
All of us have to deal with the looming threat of developing cancer during our lifetime, no matter how good our genetics are, or...

FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients | BioSpace

Medical Devices
DENVER, Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

Brick-Laying Machine Builds Without Mortar

IOT
Move over, 3D printed houses. There’s a new game in town, and it is able to use standard concrete blocks to build the walls...
12Page 1 of 2

Latest Intelligence

spot_img
spot_img

Copyright @ 2024 Plato Technologies Inc.